Analysis of costs and benefits of the Gambian Eye Care Program
- PMID: 15710822
- DOI: 10.1001/archopht.123.2.239
Analysis of costs and benefits of the Gambian Eye Care Program
Abstract
Objective: To estimate the net benefit of the Gambian Eye Care Program (GECP) using a limited definition of benefits from a societal perspective.
Methods: The number of cases of blindness avoided was modeled using population projections, population-based blindness survey estimates from 1986 and 1996, and reported blindness-related mortality differences. Benefits were measured as lifetime productivity gains that resulted from the cases of blindness avoided between the surveys. Costs included all contributions to GECP between the surveys.
Results: In 1996, 1658 fewer individuals were blind than would have been without GECP. The present value of costs was 1.28 US million dollars (1995 dollars). Although the net benefit between the blindness surveys was negative, the net lifetime benefit was 1.01 US million dollars (1995 dollars), yielding an internal rate of return of 10%. In the primary sensitivity analysis, assuming similar benefits to Senegalese citizens, who accounted for 30% of patients, the internal rate of return was 19%. Upper bound sensitivity analyses result in internal rates of return higher than 20%.
Conclusion: In one sub-Saharan African country with avoidable blindness due to cataract and eye infections, the internal rate of return of a national eye care program was substantial when using a limited definition of benefit.
Comment in
-
The Gambian Eye Care Program.Arch Ophthalmol. 2005 Feb;123(2):262. doi: 10.1001/archopht.123.2.262. Arch Ophthalmol. 2005. PMID: 15710827 No abstract available.
Similar articles
-
The Gambian Eye Care Program.Arch Ophthalmol. 2005 Feb;123(2):262. doi: 10.1001/archopht.123.2.262. Arch Ophthalmol. 2005. PMID: 15710827 No abstract available.
-
The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru.Am J Ophthalmol. 2012 Oct;154(4):750-5. doi: 10.1016/j.ajo.2012.04.003. Epub 2012 Jul 24. Am J Ophthalmol. 2012. PMID: 22831839
-
Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss.Ophthalmology. 2007 Feb;114(2):238-45. doi: 10.1016/j.ophtha.2006.07.054. Ophthalmology. 2007. PMID: 17270673
-
The global burden of cataract.Curr Opin Ophthalmol. 2011 Jan;22(1):4-9. doi: 10.1097/ICU.0b013e3283414fc8. Curr Opin Ophthalmol. 2011. PMID: 21107260 Review.
-
Preventing blindness in Americans: the need for eye health education.Surv Ophthalmol. 1995 Jul-Aug;40(1):41-4. doi: 10.1016/s0039-6257(95)80045-x. Surv Ophthalmol. 1995. PMID: 8545801 Review.
Cited by
-
The economic impact and cost of visual impairment in Australia.Br J Ophthalmol. 2006 Mar;90(3):272-5. doi: 10.1136/bjo.2005.080986. Br J Ophthalmol. 2006. PMID: 16488942 Free PMC article.
-
A case-control study to assess the relationship between poverty and visual impairment from cataract in Kenya, the Philippines, and Bangladesh.PLoS Med. 2008 Dec 16;5(12):e244. doi: 10.1371/journal.pmed.0050244. PLoS Med. 2008. PMID: 19090614 Free PMC article.
-
Barriers to use of refractive services in Mozambique.Optom Vis Sci. 2015 Jan;92(1):59-69. doi: 10.1097/OPX.0000000000000431. Optom Vis Sci. 2015. PMID: 25379630 Free PMC article.
-
Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa.BMJ Glob Health. 2017 Mar 24;2(2):e000158. doi: 10.1136/bmjgh-2016-000158. eCollection 2017. BMJ Glob Health. 2017. PMID: 28589011 Free PMC article.
-
Future trends in global blindness.Indian J Ophthalmol. 2012 Sep-Oct;60(5):387-95. doi: 10.4103/0301-4738.100532. Indian J Ophthalmol. 2012. PMID: 22944747 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources